Patents by Inventor Patrick Johnson

Patrick Johnson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12141667
    Abstract: A disclosed example includes implementing a first worker instance and a second worker instance to operate in parallel; running a first tuning operation via the first worker instance to tune first hyperparameters; running a second tuning operation via the second worker instance using a Bayesian-based optimization to determine a hyperparameter configuration to evaluate next; evaluating the hyperparameter configuration for an external model using a surrogate model; and selecting the hyperparameter configuration for the external model.
    Type: Grant
    Filed: December 23, 2021
    Date of Patent: November 12, 2024
    Assignee: Intel Corporation
    Inventors: Patrick Hayes, Michael McCourt, Alexandra Johnson, George Ke, Scott Clark
  • Patent number: 12140938
    Abstract: Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for optimizing a process of manufacturing a product. In one aspect, the method comprises repeatedly performing the following: i) selecting a configuration of input settings for manufacturing a product, based on a causal model that measures causal relationships between input settings and a measure of a quality of the product; ii) determining the measure of the quality of the product manufactured using the configuration of input settings; and iii) adjusting, based on the measure of the quality of the product manufactured using the configuration of input settings, the causal model.
    Type: Grant
    Filed: October 3, 2019
    Date of Patent: November 12, 2024
    Assignee: 3M Innovative Properties Company
    Inventors: Brian E. Brooks, Gilles J. Benoit, Peter O. Olson, Tyler W. Olson, Himanshu Nayar, Frederick J. Arsenault, Nicholas A. Johnson, Brett R. Hemes, Thomas J. Strey, Jonathan B. Arthur, Nathan J. Herbst, Aaron K. Nienaber, Sarah M. Mullins, Mark W. Orlando, Cory D. Sauer, Timothy J. Clemens, Scott L. Barnett, Zachary M. Schaeffer, Patrick G. Zimmerman, Gregory P. Moriarty, Jeffrey P. Adolf, Steven P. Floeder, Andreas Backes, Peter J. Schneider, Maureen A. Kavanagh, Glenn E. Casner, Miaoding Dai, Christopher M. Brown, Lori A. Sjolund, Jon A. Kirschhoffer, Carter C. Hughes
  • Patent number: 12131098
    Abstract: Controlling the output of audio based on the mode of an electronic device having a sound mode, silent mode, and mute mode, along different audio output routes. In the sound mode, all audio can be output, while only registered or authorized audio can be output in the silent mode. In the mute mode, no audio can be output. The sound and silent modes can be enabled using an interface of the device, while the mute mode can be enabled using an accessory coupled to the device. To disengage the mute mode, a user can provide a corresponding instruction using the accessory or providing an instruction on the device related to volume control. Other aspects are also described and claimed.
    Type: Grant
    Filed: August 17, 2023
    Date of Patent: October 29, 2024
    Assignee: Apple Inc.
    Inventors: Patrick Coffman, Meriko Borogove, Jonathan Bennett, Gregory Chapman, Anthony Guetta, Deepak Iyer, Eric Johnson
  • Publication number: 20240354847
    Abstract: Methods and systems are disclosed for providing approved financing in advance of a purchase to a buyer of an item, such as an automobile, and allowing the prospective buyer to maintain control over the financing throughout the sales process. According to disclosed embodiments, a financial service system configures a financing website for the buyer, and receives personal information as well as information relating to the desired item. The financial service system approves loan parameters for the buyer, and provides the user with a link to access the financing website on a mobile device while at a dealership. Financing parameters can thus be edited throughout the process until the final sales agreement, providing the buyer with confidence and flexibility in the buying process.
    Type: Application
    Filed: May 17, 2024
    Publication date: October 24, 2024
    Applicant: Capital One Services, LLC
    Inventors: Katherine D. FORRESTER, Patrick A. EBERLE, Nicholas DOLLE, Steven G. CHIAGOURIS, JoAnna R. HARTZMARK, Xiaoxiang ZHANG, Kurt JOHNSON, Kenneth S. CHILDS
  • Publication number: 20240336614
    Abstract: The disclosure provides compounds useful for treating alpha-1 antitrypsin deficiency (AATD), according to formula (I): tautomers thereof, pharmaceutically acceptable salts of the compounds, pharmaceutically acceptable salts of the tautomers, deuterated derivatives of the compounds, deuterated derivatives of the tautomers, and deuterated derivatives of the salts, solid forms of those compounds and processes for making those compounds.
    Type: Application
    Filed: October 16, 2023
    Publication date: October 10, 2024
    Inventors: Upul Keerthi BANDARAGE, Cavan McKeon BLIGH, Diane BOUCHER, Michael John BOYD, Michael Aaron BRODNEY, Michael Philip CLARK, Veronique DAMAGNEZ, Lev Tyler Dewey FANNING, Robert Francis FIMOGNARI, Gabrielle Simone FLEMING, Kevin James GAGNON, Pedro Manuel GARCIA BARRANTES, Robert Daniel GIACOMETTI, Simon GIROUX, Ronald Lee GREY, JR., Samantha GUIDO, Amy Beth HALL, Sarah Carol HOOD, Dennis James HURLEY, Mac Arthur JOHNSON, JR., Peter Jones, Sarathy KESAVAN, Mei-Hsiu LAI, Siying LIU, Adam LOOKER, Brad MAXWELL, John Patrick MAXWELL, Ales MEDEK, Philippe Marcel NUHANT, Kirk Alan OVERHOFF, Setu RODAY, Stefanie ROEPER, Steven M. RONKIN, Rupa SAWANT, Yi SHI, Muna SHRESTHA, Marisa SPOSATO, Kathy STAVROPOULOS, Rebecca Jane SWETT, Timothy Lewis TAPLEY, Qing TANG, Stephen THOMSON, Jinwang XU, Mariam ZAKY, Kevin Michael COTTRELL
  • Publication number: 20240334657
    Abstract: A thermal management system includes an air handling unit (AHU) configured to receive outside air (OA) from an OA intake, and water from a water source, where the AHU is configured to direct conditioned air toward a cold aisle and the AHU includes a modular adiabatic layer containing an evaporative media, and the modular adiabatic layer includes a plurality of subregions configured to be wetted by the evaporative media independently of one another.
    Type: Application
    Filed: March 27, 2023
    Publication date: October 3, 2024
    Inventors: Ehsan NASR AZADANI, Eric C. PETERSON, Winston Allen SAUNDERS, Sean Patrick ABBOTT, Mark Alan MONROE, Kristofer Andrew JOHNSON, Christian L. BELADY, Anthony Joseph BIANCHI
  • Publication number: 20240293607
    Abstract: A negative pressure device having a negative pressure source, a canister in fluid communication with the negative pressure source, a conduit the can couple with a wound dressing to provide negative pressure to a space beneath the wound dressing. Some arrangements of the negative pressure source can have a first noise reduction chamber and a second noise reduction chamber downstream of and in fluid communication with an outlet of a pump. The first and second noise reduction chambers can be configured to reduce noise generated by the pump and/or a level of pressure pulses in the fluid that is advanced through the negative pressure source.
    Type: Application
    Filed: March 23, 2022
    Publication date: September 5, 2024
    Inventors: Ben Alan Askem, William Davies, David Michael Elder, James Cunningham Glencross, Danielle Susan Johnson, Camilo Patrick Madriz, Andrea Maggiore, James Donald McLusky, Christopher John Webb, Hannah Bailey Weedon
  • Publication number: 20240293842
    Abstract: A substrate for use in an aqueous slurry has a polymeric coating to provide a compliant and sticky surface. The polymer coating has a chemical to render the surface hydrophobic so as to attract hydrophobic or hydrophobized mineral particles in the slurry. The substrate can take the form of a conveyor belt, a bead, a mesh, an impeller, a filter or a flat surface. The substrate can also be an open-cell foam. The polymeric coating can be modified with tackifiers; plasticizers; crosslinking agents; chain transfer agents; chain extenders; adhesion promoters; aryl or alky copolymers; fluorinated copolymers and/or additives; hydrophobizing agents such as hexamethyldisilazane; inorganic particles such as silica, hydrophobic silica, and/or fumed hydrophobic silica; MQ resin; and/or other additives to control and modify the properties of the polymer.
    Type: Application
    Filed: May 14, 2024
    Publication date: September 5, 2024
    Inventors: Paul J. ROTHMAN, Mark R. FERNALD, Paul DOLAN, Michael Stephen RYAN, Timothy J. BAILEY, Kirk JOHNSON, Patrick TUXBURY, Kevin Rodney LASSILA, Michael D. COPPOLA, Allison K. GREENE
  • Publication number: 20240285783
    Abstract: In some aspects, the present invention provides cell-reactive compstatin analogs and compositions comprising cell-reactive compstatin analogs. In some aspects, the invention further provides methods of using cell-reactive compstatin analogs, e.g., treat a complement-mediated disorder, e.g., to inhibit complement-mediated damage to a cell, tissue, or organ. In some aspects, the invention provides long-acting compstatin analogs and compositions comprising long-acting compstatin analogs. In some aspects, the invention further provides methods of using long-acting compstatin analogs, e.g., to treat a complement-mediated disorder, e.g., to inhibit complement-mediated damage to a cell, tissue, or organ. In some aspects, the invention provides targeted compstatin analogs and compositions comprising targeted compstatin analogs. In some aspects, the invention further provides methods of using targeted compstatin analogs, e.g., to treat a complement-mediated disorder, e.g.
    Type: Application
    Filed: November 2, 2023
    Publication date: August 29, 2024
    Applicant: Apellis Pharmaceuticals, Inc.
    Inventors: Federico Grossi, Pascal Deschatelets, Cedric Francois, Patrick Johnson, Carolina Vega
  • Publication number: 20240277354
    Abstract: An aspiration catheter including a body having a proximal end and an opposite distal tip with a lumen extending in a longitudinal direction therethrough from the proximal end to the distal tip. The aspiration catheter further includes a stabilizing structural member stabilizing the body relative to the inner wall of the vessel to minimize movement and/or radial expansion of the distal tip of the body while subject to aspiration that otherwise may potentially damage the inner wall of the vessel.
    Type: Application
    Filed: February 14, 2024
    Publication date: August 22, 2024
    Applicant: Neuravi Limited
    Inventors: Karl KEATING, AnnaLisa SMULLIN, Aoife GLYNN, Sarah JOHNSON, David QUINN, Peter MONAGHAN, Artur SPYCHALA, Petrica STEFANOV, Avril O’HIGGINS, Jane EGWARI, Colm PYNE, David VALE, Patrick GRIFFIN
  • Publication number: 20240277363
    Abstract: Cyclic aspiration system including an aspiration catheter and a cyclic aspiration source connected in fluid communication thereto, wherein the cyclic aspiration pressure source produces a cyclic aspiration pressure waveform of intermittently cycling intervals of a vacuum pressure below atmospheric pressure and a positive pressure higher than the vacuum pressure. The system further including a non-powered internal structural impediment disposed within the lumen of the aspiration catheter and configured to engage with a clot capturable therein during resulting movement between the clot and the non-powered internal structural impediment while subject to the cyclic aspiration pressure waveform to assist in capture of the clot. The non-powered internal structural impediment may be permanently attached to the aspiration catheter or a separate component or device independently slidable within the lumen of the aspiration catheter.
    Type: Application
    Filed: February 14, 2024
    Publication date: August 22, 2024
    Applicant: Neuravi Limited
    Inventors: Karl KEATING, AnnaLisa SMULLIN, Aoife GLYNN, Sarah JOHNSON, David QUINN, David VALE, Patrick GRIFFIN, Tommy GIBBONS, Chris BROOKS, Patrick BROUWER
  • Patent number: 12065429
    Abstract: The present invention relates to a compound according to formula (I) and pharmaceutically acceptable salts, hydrates, or solvates thereof. The invention further relates to said compounds for use in therapy, to pharmaceutical compositions comprising said compounds, to methods of treating diseases, e.g., dermal diseases, with said compounds, and to the use of said compounds in the manufacture of medicaments.
    Type: Grant
    Filed: December 1, 2023
    Date of Patent: August 20, 2024
    Assignee: Leo Pharma A/S
    Inventors: Mark Andrews, Mogens Larsen, Alan Jessiman, Patrick Johnson, Kevin Neil Dack
  • Publication number: 20240272280
    Abstract: A sensor pod system includes one or more sensor pods with a plurality of sensors configured to collect data from an environment. A sensor pod may have an effective field of view created by individual sensors with overlapping fields of view. The sensor pod system may include sensors of different types and modalities. Sensor pods of the sensor pod system may be modularly installed on a vehicle, for example, an autonomous vehicle and collect and provide data of the environment during operation of the vehicle.
    Type: Application
    Filed: April 8, 2024
    Publication date: August 15, 2024
    Inventors: Derek Adams, Daniel Glenn Johnson, Christopher William Labadie, Ryan McMichael, Daniel Miller, Peter Thomas Mitros, Anubhav Thakur, Joseph Patrick Warga, Austin In-Jei Yi
  • Patent number: 12048946
    Abstract: A process of coating an open-cell foam substrate includes the steps of arranging two rollers separated by a gap; positioning the substrate above the gap; providing a coating material onto the substrate, feeding the substrate through the gap so as to achieve a layer of the coating material on the substrate, wherein the coating material is selected from the group consisting of a polysiloxane derivative, acrylic polymer, butyl rubber, natural rubber, nitriles, styrene block copolymers with ethylene, styrene block copolymers with propylene, styrene block copolymers with isoprene and polyvinyl ether and modifying the coating with tackifiers; plasticizers; crosslinking agents; chain transfer agents; chain extenders; adhesion promoters; aryl or alky copolymers; fluorinated copolymers; hexamethyldisilazane; and silica.
    Type: Grant
    Filed: February 28, 2018
    Date of Patent: July 30, 2024
    Assignees: CIDRA CORPORATE SERVICES LLC, BYK-CHEMIE GMBH
    Inventors: Paul J. Rothman, Mark R. Fernald, Paul Dolan, Michael Stephen Ryan, Timothy J. Bailey, Kirk Johnson, Patrick Tuxbury, Kevin Rodney Lassila, Michael D. Coppola, Allison K. Greene
  • Publication number: 20240208938
    Abstract: The present invention relates to a compound according to formula (I) and pharmaceutically acceptable salts, hydrates, or solvates thereof. The invention further relates to said compounds for use in therapy, to pharmaceutical compositions comprising said compounds, to methods of treating diseases, e.g., dermal diseases, with said compounds, and to the use of said compounds in the manufacture of medicaments.
    Type: Application
    Filed: December 1, 2023
    Publication date: June 27, 2024
    Inventors: Mark ANDREWS, Mogens LARSEN, Alan JESSIMAN, Patrick JOHNSON, Kevin Neil DACK
  • Publication number: 20240115655
    Abstract: In some aspects, the present invention provides cell-reactive compstatin analogs and compositions comprising cell-reactive compstatin analogs. In some aspects, the invention further provides methods of using cell-reactive compstatin analogs, e.g., treat a complement-mediated disorder, e.g., to inhibit complement-mediated damage to a cell, tissue, or organ. In some aspects, the invention provides long-acting compstatin analogs and compositions comprising long-acting compstatin analogs. In some aspects, the invention further provides methods of using long-acting compstatin analogs, e.g., to treat a complement-mediated disorder, e.g., to inhibit complement-mediated damage to a cell, tissue, or organ. In some aspects, the invention provides targeted compstatin analogs and compositions comprising targeted compstatin analogs. In some aspects, the invention further provides methods of using targeted compstatin analogs, e.g., to treat a complement-mediated disorder, e.g.
    Type: Application
    Filed: February 28, 2023
    Publication date: April 11, 2024
    Inventors: Federico Grossi, Pascal Deschatelets, Cedric Francois, Patrick Johnson, Carolina Vega
  • Publication number: 20240074869
    Abstract: Methods and systems for treating a spinal joint with a facet joint replacement. The prosthesis can include a first component having a first articulating surface and a second component having a second articulating surface. The first component is attached to a superior articulating facet and the second component is attached to an inferior articulating facet. The first articulating surface and the second articulating surface articulate with each other and allow for multiple degrees of movement of the facet joint without fusing the joint.
    Type: Application
    Filed: May 1, 2023
    Publication date: March 7, 2024
    Inventors: J. Patrick Johnson, Christopher Zarembinski, Terrence T. Kim
  • Patent number: 11844841
    Abstract: In some aspects, the present invention provides cell-reactive compstatin analogs and compositions comprising cell-reactive compstatin analogs. In some aspects, the invention further provides methods of using cell-reactive compstatin analogs, e.g., treat a complement-mediated disorder, e.g., to inhibit complement-mediated damage to a cell, tissue, or organ. In some aspects, the invention provides long-acting compstatin analogs and compositions comprising long-acting compstatin analogs. In some aspects, the invention further provides methods of using long-acting compstatin analogs, e.g., to treat a complement-mediated disorder, e.g., to inhibit complement-mediated damage to a cell, tissue, or organ. In some aspects, the invention provides targeted compstatin analogs and compositions comprising targeted compstatin analogs. In some aspects, the invention further provides methods of using targeted compstatin analogs, e.g., to treat a complement-mediated disorder, e.g.
    Type: Grant
    Filed: April 29, 2021
    Date of Patent: December 19, 2023
    Assignee: Apellis Pharmaceuticals, Inc.
    Inventors: Federico Grossi, Pascal Deschatelets, Cedric Francois, Patrick Johnson, Carolina Vega
  • Patent number: D1042497
    Type: Grant
    Filed: June 27, 2022
    Date of Patent: September 17, 2024
    Assignee: Fifth Third Bank
    Inventors: Shanna Anderson, Heather R. Bowling, Katrina Rothan, Sandeep M. Basavarajaiah, Saikrishna Kondapally, Alexa Jo Hojczyk, George Edwin McLaughlin, III, Yaswanth Krishna Panchangam, Shawn T. Niehaus, Michael L. Butera, Nathan Douglas Smith, Jason Warner, Joseph Humphries, Patrick Johnson
  • Patent number: D1051919
    Type: Grant
    Filed: September 15, 2022
    Date of Patent: November 19, 2024
    Assignee: Caterpillar Inc.
    Inventors: Ramya Gangishetty, Keith Folken, Russell Loring Stott, Varun K Yellichetty, Patrick Aaron Cozad, Rajendra Behara, Edward M. Schroeder, Steve Johnson, Ryan Christopher Byrd, Jennifer Heine